Leonard S. Schleifer

2019

In 2019, Leonard S. Schleifer earned a total compensation of $21.5M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,057,162
Option Awards$11,699,586
Salary$1,377,100
Stock Awards$4,983,226
Other$338,043
Total$21,455,117

Schleifer received $11.7M in option awards, accounting for 55% of the total pay in 2019.

Schleifer also received $3.1M in non-equity incentive plan, $1.4M in salary, $5M in stock awards and $338K in other compensation.

Rankings

In 2019, Leonard S. Schleifer's compensation ranked 126th out of 13,971 executives tracked by ExecPay. In other words, Schleifer earned more than 99.1% of executives.

ClassificationRankingPercentile
All
126
out of 13,971
99th
Division
Manufacturing
46
out of 5,692
99th
Major group
Chemicals And Allied Products
10
out of 2,189
100th
Industry group
Drugs
9
out of 1,875
100th
Industry
Pharmaceutical Preparations
8
out of 1,387
99th
Source: SEC filing on April 24, 2020.

Schleifer's colleagues

We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2019.

2019

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2019

Andrew Murphy

Regeneron Pharmaceuticals

Executive Vice President, Research

2019

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2019

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

News

In-depth

You may also like


Promoted Videos

YouTube icon